Department: Medical Communications, Global Medical Affairs, Product & Portfolio Strategy (Global Business Services)
Location: Bangalore, Novo Nordisk Global Business Services (GBS), India
As a Scientific Comms. Lead, you turn complex clinical data into clear, credible medical communication that global experts and healthcare professionals can trust. You create high-impact materials and lead scientific dialogue with global key opinion leaders, helping the world understand the clinical profile of our products. Your work sharpens how medical knowledge reaches the people who shape care for those living with serious chronic diseases.
Essential:
You will join Medical Communications within Global Medical Affairs, part of Product & Portfolio Strategy in Global Business Services, based in Bangalore, India. In Product & Portfolio Strategy, colleagues connect commercial strategy, medical affairs and business development across therapy areas, helping guide the Novo portfolio and strengthen competitiveness.
Your team brings together global scientific advisors, project managers and graphic designers.
Together, you will partner closely with the Global Medical Affairs teams in Denmark, communicating scientific and medical knowledge on our products to the external scientific community and across the organisation. The atmosphere is dynamic and fast-paced, with a strong focus on teamwork and scientific excellence. You will also work directly with global key opinion leaders, including on-site engagement at meetings and symposia.
You will work in an international, collaborative environment where scientific rigour is valued and your voice is heard. The role offers the chance to broaden your expertise across therapy areas, build new skills through cross-functional and cross-market collaboration, and develop lasting relationships with leading experts in the field.
You will be trusted to take ownership of your work and supported to perform at your best, in a team that combines curiosity, collaboration and ambition to create meaningful progress.
Your impact begins today. If you are ready to turn complex science into clear, credible communication that reaches the experts shaping care, apply for the Scientific Comms. Lead role by 7 October 2026. Applications are reviewed on an ongoing basis, so we encourage you to apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html